THE ASSOCIATION BETWEEN POST-PROCEDURAL STENT ASYMMETRY AND SUBSEQUENT STENT COVERAGE AND NEOINTIMAL HYPERPLASIA ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY: THE EGO-BIOFREEDOM AND OCT-ORION STUDIES

There are limited data regarding the impact of asymmetric stent expansion on subsequent stent coverage and neointimal hyperplasia (NIH) in the contemporary drug-eluting stent era. EGO-BIOFREEDOM (BioFreedom stent in 105 lesions, 99 pts) and EGO-ORION (randomized Resolute vs BioMatrix stent in 119